Medical Device News Magazine

Dayzz Sleep App Announces Publication of the Findings From Clinical Trial to Validate Its Sleep Assessment Machine Learning Engine

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

June 25, 2020

Innovative sleep solution provider dayzz announced this week the results of its first clinical trial. dayzz’ machine learning engine enables assessment of common sleep disturbances using a proprietary questionnaire. The clinical trial was conducted in collaboration with the Johns Hopkins Center for Interdisciplinary Sleep Research and Education.

In the U.S., more than 30% of the adult population suffer from sleep problems, and it is estimated that 50-70 million Americans have a sleep disorder that affects their health and quality of life. Many of them are undiagnosed and untreated. Insufficient sleep alone costs the US economy over $400 billion a year, and sleep problems among employees have huge financial implications on employers and payers. dayzz has developed and validated the Digital Sleep Questionnaire (DSQ) to identify common societal sleep disturbances including insomnia, delayed sleep phase syndrome, insufficient sleep syndrome, and risk for obstructive sleep apnea.

“dayzz’ machine learning algorithm was trained on gold-standard sleep expert diagnoses of people in the community with common sleep complaints and has shown high accuracy in predicting those at risk for prevalent sleep disorders,” said Dr. Mairav Cohen-Zion, Chief Science Officer at dayzz. “This is a critical step forward for dayzz in identifying sleep disorders at scale and offering a personalized sleep training experience for our users.”

In the upcoming months, dayzz will launch a randomized clinical trial in collaboration with researchers at Brigham and Women’s Hospital and Harvard Medical School to examine the effectiveness of its solution in a large community-based organizational setting. Read more here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”